3-[4-(cyclohexylamino)-1H-pyrazolo[4,3-c]pyridin-3-yl]benzonitrile;[3-[4-(cyclohexylamino)-1H-pyrazolo[4,3-c]pyridin-3-yl]phenyl]-morpholin-4-ylmethanone;N-cyclohexyl-3-(3-methylphenyl)-1H-pyrazolo[4,3-c]pyridin-4-amine;N-cyclohexyl-3-(4-morpholin-4-ylphenyl)-1H-pyrazolo[4,3-c]pyridin-4-amine;N-cyclohexyl-3-(6-morpholin-4-yl-3-pyridinyl)-1H-pyrazolo[4,3-c]pyridin-4-amine;N-cyclohexyl-3-[2-(trifluoromethoxy)phenyl]-1H-pyrazolo[4,3-c]pyridin-4-amine
C123H140F3N29O5 — CID 158832814
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-[4-(cyclohexylamino)-1H-pyrazolo[4,3-c]pyridin-3-yl]benzonitrile;[3-[4-(cyclohexylamino)-1H-pyrazolo[4,3-c]pyridin-3-yl]phenyl]-morpholin-4-ylmethanone;N-cyclohexyl-3-(3-methylphenyl)-1H-pyrazolo[4,3-c]pyridin-4-amine;N-cyclohexyl-3-(4-morpholin-4-ylphenyl)-1H-pyrazolo[4,3-c]pyridin-4-amine;N-cyclohexyl-3-(6-morpholin-4-yl-3-pyridinyl)-1H-pyrazolo[4,3-c]pyridin-4-amine;N-cyclohexyl-3-[2-(trifluoromethoxy)phenyl]-1H-pyrazolo[4,3-c]pyridin-4-amine
3-[4-(cyclohexylamino)-1H-pyrazolo[4,3-c]pyridin-3-yl]benzonitrile;[3-[4-(cyclohexylamino)-1H-pyrazolo[4,3-c]pyridin-3-yl]phenyl]-morpholin-4-ylmethanone;N-cyclohexyl-3-(3-methylphenyl)-1H-pyrazolo[4,3-c]pyridin-4-amine;N-cyclohexyl-3-(4-morpholin-4-ylphenyl)-1H-pyrazolo[4,3-c]pyridin-4-amine;N-cyclohexyl-3-(6-morpholin-4-yl-3-pyridinyl)-1H-pyrazolo[4,3-c]pyridin-4-amine;N-cyclohexyl-3-[2-(trifluoromethoxy)phenyl]-1H-pyrazolo[4,3-c]pyridin-4-amine (PubChem CID 158832814) has the molecular formula C123H140F3N29O5 and a molecular weight of 2161.66 g/mol. Its IUPAC name is 3-[4-(cyclohexylamino)-1H-pyrazolo[4,3-c]pyridin-3-yl]benzonitrile;[3-[4-(cyclohexylamino)-1H-pyrazolo[4,3-c]pyridin-3-yl]phenyl]-morpholin-4-ylmethanone;N-cyclohexyl-3-(3-methylphenyl)-1H-pyrazolo[4,3-c]pyridin-4-amine;N-cyclohexyl-3-(4-morpholin-4-ylphenyl)-1H-pyrazolo[4,3-c]pyridin-4-amine;N-cyclohexyl-3-(6-morpholin-4-yl-3-pyridinyl)-1H-pyrazolo[4,3-c]pyridin-4-amine;N-cyclohexyl-3-[2-(trifluoromethoxy)phenyl]-1H-pyrazolo[4,3-c]pyridin-4-amine.
Molecular Properties
| Compound Name | 3-[4-(cyclohexylamino)-1H-pyrazolo[4,3-c]pyridin-3-yl]benzonitrile;[3-[4-(cyclohexylamino)-1H-pyrazolo[4,3-c]pyridin-3-yl]phenyl]-morpholin-4-ylmethanone;N-cyclohexyl-3-(3-methylphenyl)-1H-pyrazolo[4,3-c]pyridin-4-amine;N-cyclohexyl-3-(4-morpholin-4-ylphenyl)-1H-pyrazolo[4,3-c]pyridin-4-amine;N-cyclohexyl-3-(6-morpholin-4-yl-3-pyridinyl)-1H-pyrazolo[4,3-c]pyridin-4-amine;N-cyclohexyl-3-[2-(trifluoromethoxy)phenyl]-1H-pyrazolo[4,3-c]pyridin-4-amine |
|---|---|
| PubChem CID | 158832814 |
| Molecular Formula | C123H140F3N29O5 |
| Molecular Weight | 2161.66 g/mol |
| Exact Mass | 2160.15 |
| IUPAC Name | 3-[4-(cyclohexylamino)-1H-pyrazolo[4,3-c]pyridin-3-yl]benzonitrile;[3-[4-(cyclohexylamino)-1H-pyrazolo[4,3-c]pyridin-3-yl]phenyl]-morpholin-4-ylmethanone;N-cyclohexyl-3-(3-methylphenyl)-1H-pyrazolo[4,3-c]pyridin-4-amine;N-cyclohexyl-3-(4-morpholin-4-ylphenyl)-1H-pyrazolo[4,3-c]pyridin-4-amine;N-cyclohexyl-3-(6-morpholin-4-yl-3-pyridinyl)-1H-pyrazolo[4,3-c]pyridin-4-amine;N-cyclohexyl-3-[2-(trifluoromethoxy)phenyl]-1H-pyrazolo[4,3-c]pyridin-4-amine |
| SMILES | Cc1cccc(-c2n[nH]c3ccnc(NC4CCCCC4)c23)c1.FC(F)(F)Oc1ccccc1-c1n[nH]c2ccnc(NC3CCCCC3)c12.N#Cc1cccc(-c2n[nH]c3ccnc(NC4CCCCC4)c23)c1.O=C(c1cccc(-c2n[nH]c3ccnc(NC4CCCCC4)c23)c1)N1CCOCC1.c1cc2[nH]nc(-c3ccc(N4CCOCC4)cc3)c2c(NC2CCCCC2)n1.c1cc2[nH]nc(-c3ccc(N4CCOCC4)nc3)c2c(NC2CCCCC2)n1 |
| InChI | InChI=1S/C23H27N5O2.C22H27N5O.C21H26N6O.C19H19F3N4O.C19H19N5.C19H22N4/c29-23(28-11-13-30-14-12-28)17-6-4-5-16(15-17)21-20-19(26-27-21)9-10-24-22(20)25-18-7-2-1-3-8-18;1-2-4-17(5-3-1)24-22-20-19(10-11-23-22)25-26-21(20)16-6-8-18(9-7-16)27-12-14-28-15-13-27;1-2-4-16(5-3-1)24-21-19-17(8-9-22-21)25-26-20(19)15-6-7-18(23-14-15)27-10-12-28-13-11-27;20-19(21,22)27-15-9-5-4-8-13(15)17-16-14(25-26-17)10-11-23-18(16)24-12-6-2-1-3-7-12;20-12-13-5-4-6-14(11-13)18-17-16(23-24-18)9-10-21-19(17)22-15-7-2-1-3-8-15;1-13-6-5-7-14(12-13)18-17-16(22-23-18)10-11-20-19(17)21-15-8-3-2-4-9-15/h4-6,9-10,15,18H,1-3,7-8,11-14H2,(H,24,25)(H,26,27);6-11,17H,1-5,12-15H2,(H,23,24)(H,25,26);6-9,14,16H,1-5,10-13H2,(H,22,24)(H,25,26);4-5,8-12H,1-3,6-7H2,(H,23,24)(H,25,26);4-6,9-11,15H,1-3,7-8H2,(H,21,22)(H,23,24);5-7,10-12,15H,2-4,8-9H2,1H3,(H,20,21)(H,22,23) |
| InChIKey | IXGLQETWNVUOPB-UHFFFAOYSA-N |
| XLogP | 25.84 |
| TPSA | 421.99 Ų |
| H-Bond Donors | 12 |
| H-Bond Acceptors | 27 |
| Rotatable Bonds | 22 |
| Heavy Atoms | 160 |
| Complexity | — |
Lipinski Rule of Five
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2161.66 |
| LogP ≤ 5 | 25.84 |
| H-Bond Donors ≤ 5 | 12 |
| H-Bond Acceptors ≤ 10 | 27 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158832814 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.